Literature DB >> 12764102

Synapse number and synaptic efficacy are regulated by presynaptic cAMP and protein kinase A.

David W Munno1, David J Prince, Naweed I Syed.   

Abstract

The mechanisms by which neurons regulate the number and strength of synapses during development and synaptic plasticity have not yet been defined fully. This lack of fundamental knowledge in the fields of neurodevelopment and synaptic plasticity can be attributed, in part, to compensatory mechanisms by which neurons accommodate for the loss of function in their synaptic partners. This is generally achieved either by scaling up neuronal transmitter release capabilities or by enhancing the postsynaptic responsiveness. Here, we demonstrate that regulation of synaptic strength and number between identified Lymnaea neurons visceral dorsal 4 (VD4, the presynaptic cell) and left pedal dorsal 1 (LPeD1, the postsynaptic cell) requires presynaptic activation of a cAMP-PKA-dependent signal. Experimental activation of the cAMP-PKA pathway resulted in reduced synaptic efficacy, whereas inhibition of the cAMP-PKA cascade permitted hyperinnervation and an overall enhancement of synaptic strength. Because synaptic transmission between VD4 and LPeD1 does not require a cAMP-PKA pathway, our data show that these messengers may play a novel role in regulating the synaptic efficacy during early synaptogenesis and plasticity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12764102      PMCID: PMC6741068     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  8 in total

Review 1.  Synaptogenesis in the CNS: an odyssey from wiring together to firing together.

Authors:  David W Munno; Naweed I Syed
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

2.  Lidocaine treatment during synapse reformation periods permanently inhibits NGF-induced excitation in an identified reconstructed synapse of Lymnaea stagnalis.

Authors:  Shin Onizuka; Seiji Shiraishi; Ryuuji Tamura; Tetsu Yonaha; Nobuko Oda; Yuko Kawasaki; Naweed I Syed; Tetsuro Shirasaka; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2011-10-30       Impact factor: 2.078

3.  Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus.

Authors:  Chiara Ristori; Maurizio Cammalleri; Davide Martini; Barbara Pavan; Yanqiang Liu; Giovanni Casini; Massimo Dal Monte; Paola Bagnoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-30       Impact factor: 3.000

4.  Spinal activation of the cAMP-PKA pathway induces respiratory motor recovery following high cervical spinal cord injury.

Authors:  S Kajana; H G Goshgarian
Journal:  Brain Res       Date:  2008-07-12       Impact factor: 3.252

5.  Prenatal interleukin 6 elevation increases glutamatergic synapse density and disrupts hippocampal connectivity in offspring.

Authors:  Filippo Mirabella; Genni Desiato; Sara Mancinelli; Giuliana Fossati; Marco Rasile; Raffaella Morini; Marija Markicevic; Christina Grimm; Clara Amegandjin; Alberto Termanini; Clelia Peano; Paolo Kunderfranco; Graziella di Cristo; Valerio Zerbi; Elisabetta Menna; Simona Lodato; Michela Matteoli; Davide Pozzi
Journal:  Immunity       Date:  2021-11-09       Impact factor: 31.745

6.  Cloning and characterization of a P2X receptor expressed in the central nervous system of Lymnaea stagnalis.

Authors:  Selvan Bavan; Volko A Straub; Tania E Webb; Steven J Ennion
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

7.  cAMP-Inhibits Cytoplasmic Phospholipase A₂ and Protects Neurons against Amyloid-β-Induced Synapse Damage.

Authors:  Clive Bate; Alun Williams
Journal:  Biology (Basel)       Date:  2015-09-16

8.  Neurotrophic factors and target-specific retrograde signaling interactions define the specificity of classical and neuropeptide cotransmitter release at identified Lymnaea synapses.

Authors:  Angela M Getz; Tara A Janes; Frank Visser; Wali Zaidi; Naweed I Syed
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.